title: [Treatment of high blood cholesterol in patients with coronary heart disease].
authors.affiliation: Department of Internal Medicine, Izumisano City Hospital.
authors.forename: Y
authors.initials: Y
authors.lastname: Nagai
authors.forename: K
authors.initials: K
authors.lastname: Yanagi
authors.forename: S
authors.initials: S
authors.lastname: Yamashita
authors.forename: K
authors.initials: K
authors.lastname: Takemura
authors.forename: Y
authors.initials: Y
authors.lastname: Matsuzawa
mesh_terms: D000837:Anion Exchange Resins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001629:Bezafibrate / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009525:Niacin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011341:Probucol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000837:Anion Exchange Resins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D009525:Niacin; D011341:Probucol; D001629:Bezafibrate